Vanguard Personalized Indexing Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Buy
3,240
+59
+2% +$17.4K 0.01% 1047
2026
Q1
$945K Sell
3,181
-89
-3% -$28.8K 0.01% 962
2025
Q4
$993K Buy
3,270
+486
+17% +$159K 0.01% 913
2025
Q3
$949K Buy
2,784
+565
+25% +$172K 0.01% 933
2025
Q2
$537K Buy
2,219
+753
+51% +$185K 0.01% 1168
2025
Q1
$399K Buy
+1,466
New +$343K 0.01% 1215
2024
Q4
Sell
-1,538
Closed -$345K 1883
2024
Q3
$345K Buy
+1,538
New +$277K 0.01% 1278
2024
Q2
Sell
-1,445
Closed -$226K 1761
2024
Q1
$226K Buy
1,445
+192
+15% +$30.9K ﹤0.01% 1398
2023
Q4
$226K Sell
1,253
-451
-26% -$81.6K 0.01% 1359
2023
Q3
$306K Buy
1,704
+78
+5% +$15.4K 0.01% 1119
2023
Q2
$290K Sell
1,626
-15
-0.9% -$3.45K 0.01% 1154
2023
Q1
$354K Buy
1,641
+68
+4% +$16.3K 0.01% 1032
2022
Q4
$346K Buy
+1,573
New +$288K 0.01% 926
2021
Q4
Sell
-765
Closed -$278K 1117
2021
Q3
$278K Buy
765
+129
+20% +$42.2K 0.03% 791
2021
Q2
$218K Buy
636
+1
+0.2% +$331 0.02% 864
2021
Q1
$221K Buy
+635
New +$210K 0.03% 641

Other funds holding ONC

Vanguard Personalized Indexing Management's ONC Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its BeOne Medicines Ltd (ONC) stake by 1.9% in Q2 2026, buying an estimated $17.4K and bringing the position to 3,240 shares worth $923K. The position accounts for 0.01% of the portfolio, ranked #1047.

Vanguard Personalized Indexing Management first reported a position in ONC in Q1 2021 and has held it in 16 quarters since. The position peaked at $993K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Vanguard Personalized Indexing Management held 3,240 shares of BeOne Medicines Ltd worth $923K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 59 BeOne Medicines Ltd shares in Q2 2026, an estimated $17.4K.
  • BeOne Medicines Ltd made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1047 holding.
  • Vanguard Personalized Indexing Management first reported a position in BeOne Medicines Ltd in Q1 2021 and has held it in 16 quarters since.
  • Vanguard Personalized Indexing Management's BeOne Medicines Ltd position peaked at $993K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.